TECHNOLOGIES IN DEVELOPMENT

Many products introduced into low- and middle-income countries fail because of an inadequate understanding of the factors required for successful utilization. To be effective in low-resource settings, especially at the community level, technologies must meet operational and performance requirements consistent with the community setting and the skills of community health workers who may be the primary users of the technology. We’ve collected many technologies in development that address some of these requirements. We invite you to review these technologies in development and submit comments. Please use the search function to narrow your focus by condition, development status, or keyword. You may also submit a technology.

Search
See options to Filter through all the technologies in developments
Maternal
Neonatal
Keywords
Development status
Revise List Below
Maternal-Fetal Monitoring System

Maternal-Fetal Monitoring System

CONDITION(S) ADDRESSED: PRE-ECLAMPSIA
  Neil Euliano of Convergent Engineering in the U.S. is developing and testing a maternal-fetal monitoring system that uses reusable capacitive sensors and smart phones that provide early ...Read More
Last Update: 2.21.13
TYPE
STAGE
Clinical studies
FUNDING
Bill & Melinda Gates Foundation
Maternova Obstetric Kit

Maternova Obstetric Kit

CONDITION(S) ADDRESSED: ATONIC UTERUS
Application: Designed for trained midwives and birth attendants in clinical/home, low-resource settings Function: Tools to diagnose and manage post partum hemorrhage (PPH) including: ...Read More
Last Update: 2.21.13
TYPE
Prevention
STAGE
Clinical studies
FUNDING
The Kopernik
Melatonin

Melatonin

CONDITION(S) ADDRESSED: BIRTH ASPHYXIA
  Euan Wallace of The Ritchie Centre in Australia proposes to test the antioxidant melatonin as a simple and inexpensive intervention to reduce birth-related brain injury.   ...Read More
Last Update: 2.21.13
TYPE
STAGE
Clinical studies
FUNDING
Bill & Melinda Gates Foundation
Miraculins Pre-Eclampsia Markers

Miraculins Pre-Eclampsia Markers

CONDITION(S) ADDRESSED: PRE-ECLAMPSIA
Application Dual use in developed and developing countries;   Advantages First major development of a reliable biomarker diagnostic that can accurately predict the on...Read More
Last Update: 2.21.13
TYPE
STAGE
Clinical studies
FUNDING
Commercialization license in place
Misoprostol

Misoprostol

CONDITION(S) ADDRESSED: ATONIC UTERUS
Application WHO recommends misoprostol as a third-line treatment for PPH and for prevention where parenteral uterotonics are not available or feasible.  ; Subsequent to the 18...Read More
Last Update: 2.21.13
TYPE
STAGE
Clinical studies
FUNDING
Gynuity Health Projects and Venture Strategies for
Mobisante Mobile Ultrasound

Mobisante Mobile Ultrasound

CONDITION(S) ADDRESSED: HEMORRHAGE, PREMATURITY
  Description: Smartphone-based ultrasound system allows mobile use of ultrasound in both high- and low-resource settings   Advantages: FDA Approved; Images ...Read More
Last Update: 2.7.13
TYPE
Diagnostic, Prevention, Treatment
STAGE
Clinical studies
FUNDING
Morriston Pneumatic Ventilator

Morriston Pneumatic Ventilator

CONDITION(S) ADDRESSED: RESPIRATORY DISTRESS SYNDROME
Application Any clinical setting with an oxygen source (dual use);   Advantages Gas efficient; No pressurized air or electrical requirements; Provide effe...Read More
Last Update: 2.21.13
TYPE
Treatment
STAGE
Clinical studies
FUNDING
mTor Preterm Diagnostic

mTor Preterm Diagnostic

CONDITION(S) ADDRESSED: PREMATURITY
  S.K. Dey of Cincinnati Children's Hospital Medical Center in the U.S. will test the hypothesis that the protein mTor, which regulates cell growth and survival, plays a critical role ...Read More
Last Update: 2.21.13
TYPE
Diagnostic
STAGE
Clinical studies
FUNDING
Bill & Melinda Gates Foundation
MTTS CPAP

MTTS CPAP

CONDITION(S) ADDRESSED: RESPIRATORY DISTRESS SYNDROME
Application Designed for use in low-resource district hospitals that have access to oxygen and a reliable power source but do not have ventilatory support for infants;   Adva...Read More
Last Update: 2.7.13
TYPE
Prevention, Treatment
STAGE
Clinical studies
FUNDING
Lemelson Foundation; Limited Brand; Niles Foundati
NBM 200 Non Invasive Hemoglobin

NBM 200 Non Invasive Hemoglobin

CONDITION(S) ADDRESSED: ANEMIA
  Description: Anemia Screening and Monitoring in public health including Maternal and Child health non invasive hemorrhage detection   Advantages: Accurate, non-i...Read More
Last Update: 4.2.13
TYPE
Diagnostic
STAGE
Clinical studies
FUNDING
Private